vor 5 Jahren

Dermapharm-Aktie: Die Kooperation mit BioNTech zahlt sich aus

Dermapharm und Biontech haben im September eine Kooperation ihrer Produktionstochtergesellschaften bei der Herstellung des Covid-19-Impfstoffes vereinbart. Daneben wächst Dermapharm organisch und über Zukäufe. Die Aktie bleibt trotz Kurssprungvielversprechend. Von Petra Maier

Quelle: Börse Online RSS Feed

Australia Approves First Bitcoin-Backed Mortgage After Legal Winvor 2 Stunden
Just bought some BTC for the first time I'm 19 hopefully the reoccurring payments will be worth it in the long run.vor 3 Stunden
Charles Schwab to Launch Bitcoin and Ethereum Tradingvor 6 Stunden
"Should have bought some"vor 7 Stunden
Have you moved BCH onto EVM chains? How did you deal with fees and lag?vor 7 Stunden
The amount of Bitcoin you needed to retire depends on the country you live in.vor 8 Stunden
Reminder: MIT's Digital Currency Initiative was funded, in part, by foundations controlled by the infamous pedophile Jeffery Epstein. If the development of a project is controlled by compromised people, it's probably not going to win in the long run.vor 8 Stunden
Me telling people about my investment strategyvor 9 Stunden
Good ol' pre-2018 when you can earn bitcoin from just playing flash games.vor 9 Stunden
Whale finishes selling their 80k BTC for 9.5 Billion dollars.vor 9 Stunden